A randomized trial of nicotine-replacement therapy patches in pregnancy.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nicotine-replacement therapy is effective for smoking cessation outside pregnancy and its use is widely recommended during pregnancy. We investigated the efficacy and safety of nicotine patches during pregnancy. METHODS: We recruited participants from seven hospitals in England who were 16 to 50 years of age with pregnancies of 12 to 24 weeks' gestation and who smoked five or more cigarettes per day. Participants received behavioral cessation support and were randomly assigned to 8 weeks of treatment with active nicotine patches (15 mg per 16 hours) or matched placebo patches. The primary outcome was abstinence from the date of smoking cessation until delivery, as validated by measurement of exhaled carbon monoxide or salivary cotinine. Safety was assessed by monitoring for adverse pregnancy and birth outcomes. RESULTS: Of 1050 participants, 521 were randomly assigned to nicotine-replacement therapy and 529 to placebo. There was no significant difference in the rate of abstinence from the quit date until delivery between the nicotine-replacement and placebo groups (9.4% and 7.6%, respectively; unadjusted odds ratio with nicotine-replacement therapy, 1.26; 95% confidence interval, 0.82 to 1.96), although the rate was higher at 1 month in the nicotine-replacement group than in the placebo group (21.3% vs. 11.7%). Compliance was low; only 7.2% of women assigned to nicotine-replacement therapy and 2.8% assigned to placebo used patches for more than 1 month. Rates of adverse pregnancy and birth outcomes were similar in the two groups. CONCLUSIONS: Adding a nicotine patch (15 mg per 16 hours) to behavioral cessation support for women who smoked during pregnancy did not significantly increase the rate of abstinence from smoking until delivery or the risk of adverse pregnancy or birth outcomes. However, low compliance rates substantially limited the assessment of safety. (Funded by the National Institute for Health Research Health Technology Assessment Programme; Current Controlled Trials number, ISRCTN07249128.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All seven included RCTs (N=2,285) were designed to test the effectiveness of NRT on smoking cessation and reported infant, child, and maternal health.[93](#R93),[94](#R94),[97](#R97),[100](#R100)-[102](#R102),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“Five placebo-controlled trials reported on preterm birth (delivery at <37 weeks gestation).[93](#R93),[94](#R94),[100](#R100),[101](#R101),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“All seven trials reported the association between NRT and mean birthweight.[93](#R93),[94](#R94),[97](#R97),[100](#R100)-[102](#R102),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“Within the other trials, one (N=403) reported similar numbers of women with preterm birth in the NRT and placebo groups (14.0% vs. 13.5%, respectively),[93](#R93)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“There was no evidence of perinatal harms related to NRT use among pregnant women, but data for assessing rare harms were very limited.”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., RICKERT, W., & ROBINSON, J. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03059.x · Cited by 1,313
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Cnattingius, S. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001669187 · Cited by 1,126
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Nicotine receptor partial agonists for smoking cessation
Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 861
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Accelerated Metabolism of Nicotine and Cotinine in Pregnant Smokers
Dempsey, D., Jacob, P., & Benowitz, N. L. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.594 · Cited by 452
Nicotine patches for pregnant smokers: a randomized controlled study
Wisborg, K. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01071-1 · Cited by 218
Nicotine receptor partial agonists for smoking cessation (Review)
Cahill, K., Lf, S., & Lancaster, T. (2007) · Cited by 205
Tobacco and pregnancy: Overview of exposures and effects
Rogers, J. M. (2008) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20119 · Cited by 195
Self‐reported smoking, cotinine levels, and patterns of smoking in pregnancy
Pickett, K. E., Rathouz, P. J., Kasza, K., Wakschlag, L. S., & Wright, R. (2005) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2005.00660.x · Cited by 183
Balmford, J., Borland, R., Hammond, D., & Cummings, K. M. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq215 · Cited by 158
Nicotine replacement and behavioral therapy for smoking cessation in pregnancy.
Pollak, K. I., Oncken, C. A., Lipkus, I. M., Lyna, P., Swamy, G. K., Pletsch, P. K., Peterson, B. L., Heine, R. P., Brouwer, R. J. N., Fish, L., et al. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.05.006 · Cited by 137
Fluctuations of maternal smoking during pregnancy
Pickett, K. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02370-0 · Cited by 122
Nicotine Gum for Pregnant Smokers: A Randomized Controlled Trial
Oncken, C., Dornelas, E., Greene, J., Sankey, H., Glasmann, A., Feinn, R., & Kranzler, H. R. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318187e1ec · Cited by 114
Windsor, R. A., Woodby, L. L., Miller, T. M., Hardin, J. M., Crawford, M. A., & DiClemente, C. C. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70492-3 · Cited by 108
Coleman, T., Chamberlain, C., Cooper, S., & Leonardi-Bee, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03179.x · Cited by 104
Self-citationThe use of pharmacotherapies for smoking cessation during pregnancy
Benowitz, N. L. (2000) · Tobacco Control · doi:10.1136/tc.9.suppl_3.iii91 · Cited by 72
Smoking patterns during pregnancy and postnatal period and depressive symptoms
Munafo, M., Heron, J., & Araya, R. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802412895 · Cited by 70
Coleman, T., Thornton, J., Britton, J., Lewis, S., Watts, K., Coughtrie, M. W., Mannion, C., Marlow, N., & Godfrey, C. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-2 · Cited by 48
Self-citation
Research works printed but not linked: 4
- Lumley J, 2009, Cochrane Database Syst Rev, 3, CD001055
- Cahill K, 2007, Cochrane Database Syst Rev, 1, CD006103
- Hughes JR, 2007, Cochrane Database Syst Rev, 1, CD000031
- Stead LF, 2008, Cochrane Database Syst Rev, 1, CD000146
Cited by
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
“We now include six trials of NRT in pregnant women in the review (Berlin 2014; Coleman 2012; El-Mohandes 2013; Oncken 2007; Pollak 2007; Wisborg 2000) with Coleman 2012 contributing over 1000 of around 2100 participants.”
BackgroundMethodInfluentialRETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Magee, L. A., Helewa, M., Rey, E., Cardew, S., Côté, A.-M., Douglas, M. J., Firoz, T., Gibson, P. S., Gruslin A., A., Lange, I., et al. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32776-1 · Cited by 578
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
Magee, L. A., Pels, A., Helewa, M., Rey, E., & von Dadelszen, P. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.01.003 · Cited by 448
“Nicotine replacement therapy in pregnancy neither improves quit rates in pregnancy nor alters adverse outcomes [237].”
BackgroundPharmacological interventions for promoting smoking cessation during pregnancy
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S. E., & Leonardi-Bee, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub2 · Cited by 357
Self-citation
Metadata
- Authors
- Coleman, T., Cooper, S., Thornton, J. G., Grainge, M. J., Watts, K., Britton, J., & Lewis, S.
- Affiliations
- University of Nottingham (GB)
- National Institute for Health and Care Research (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-03
- Volume
- 366
- Issue
- 9
- Pages
- 808-818
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132635946
- Semantic Scholar
- c5640a53023f2749177b54ed3b04e7193c716b47
- Cited by
- 190
- References
- 24
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 18 · 2018: 8 · 2017: 15 · 2016: 19 · 2015: 23 · 2014: 23 · 2013: 18 · 2012: 17
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (06/07/01)
- Economic and Social Research Council (ES/G007489/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- nicotine replacement therapy, nicotine patch, smoking cessation, pregnancy, maternal smoking, birth outcomes, adverse pregnancy outcomes, exhaled carbon monoxide, salivary cotinine
- MeSH terms
- Administration, Cutaneous, Adult, Behavior Therapy, Cesarean Section, Double-Blind Method, Female, Follow-Up Studies, Humans, Nicotine, Pregnancy, Pregnancy Complications, Smoking Cessation, Medication Adherence, Tobacco Use Cessation Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.